Teaching AI the biology of antibodies speeds drug discovery
Designing an effective antibody drug is like searching for the right key in a warehouse of locks. Scientists may begin with millions—or even billions—of antibody candidates, but only a tiny fraction will recognize and bind tightly to the disease target. Identifying those rare candidates has long been one of the biggest challenges in developing antibody medicines.
We haven't written up this one. Phys.org has the full story — the link below goes straight to it.
